Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
POD | Record Platinum deficit 23/24 -POD AUS largest Plat resource | 18/03/24 | 130 | 44K | |||
|
|||||||
POD | Ann: Response to ASX Price Query | 14/03/24 | 12 | 2.6K | |||
|
|||||||
POD | Ann: Notification regarding unquoted securities - POD | 28/02/24 | 0 | 144 | |||
|
|||||||
POD | Ann: Issue of Securities and Notification of Directors' Interests | 28/02/24 | 0 | 163 | |||
|
|||||||
POD | Ann: Half Year Financial Report - 31 December 2023 | 21/02/24 | 0 | 263 | |||
|
|||||||
POD | Ann: Notification of Directors' Interests | 15/02/24 | 5 | 1.5K | |||
|
|||||||
POD | Ann: Notification of cessation of securities - POD | 09/02/24 | 0 | 238 | |||
|
|||||||
POD | Ann: Notification regarding unquoted securities - POD | 09/02/24 | 0 | 209 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |